the patient

Anxiety, Depression, and Narcissism


 

Anxiety, Depression, and Narcissism – WARNING: This video requires acquaintance with professional terms in psychoanalysis and object relations theories. For a POPULAR TREATMENT of this topic, wat…

 

New Moms at Risk for Depressive Disorders
Additionally in the screening… Continue reading

Statin-Associated Polymyositis Following Omeprazole Treatment.

Statin-Associated Polymyositis Following Omeprazole Treatment.

Clin Med Res. 2013 Apr 11;
Kanth R, Shah MS, Flores RM

Statins are an extensively used class of drugs, and myopathy is an uncommon, but well-described side effect of statin therapy. Inflammatory myopathies,… Continue reading

The Lack of Association Between Components of Metabolic Syndrome and Treatment Resistance in Depression.

The lack of association between components of metabolic syndrome and treatment resistance in depression.

Psychopharmacology (Berl). 2013 Apr 12;
Sagud M, Mihaljevic-Peles A, Uzun S, Cusa BV, Kozumplik O, Kudlek-Mikulic S, Mustapic M, Barisic I, Muck-Seler D, Pivac N… Continue reading

Combined Approach With Therapeutic Drug Monitoring and Pharmacogenomics in Renal Transplant Recipients.

Combined approach with therapeutic drug monitoring and pharmacogenomics in renal transplant recipients.

Indian J Nephrol. 2013 Jan; 23(1): 71-3
Manvizhi S, Mathew BS, Fleming DH, Basu G, John GT

In patients undergoing renal transplantation, dose individualization for tacrolimus is routinely achieved with therapeutic drug monitoring (TDM). The patient started on 5.5 mg/day of tacrolimus had a significantly elevated tacrolimus trough concentration. The tacrolimus dose was regularly reduced following TDM at many time periods in the post transplant period but the tacrolimus concentration was consistently elevated. Genomic analysis done after four years revealed mutations in the genes encoding for CYP3A5 and MDR1 (2677G > T). Pharmacogenomics alongside TDM, will soon emerge as the backbone… Continue reading

Quality of Life in Obsessive-Compulsive Disorder: Impact of the Disorder and of Treatment.

Quality of Life in Obsessive-Compulsive Disorder: Impact of the Disorder and of Treatment.

CNS Drugs. 2013 Apr 12;
Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA

Obsessive-compulsive disorder (OCD) is a chronic debilitating anxiety disorder characterized by… Continue reading

Patterns of Changes in Wheelchair Exercise Capacity After Spinal Cord Injury.

Patterns of changes in wheelchair exercise capacity after spinal cord injury.

Arch Phys Med Rehabil. 2013 Mar 16;
van Koppenhagen CF, de Groot S, Post MW, Hoekstra T, van Asbeck FW, Bongers W, Lindeman E, van der Woude LH… Continue reading

Patient Characteristics Associated With Medication Adherence.

Patient Characteristics Associated with Medication Adherence.

Clin Med Res. 2013 Apr 11;
Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ

ObjectiveDespite evidence indicating therapeutic benefit for adhering to a prescribed regimen, many patients do not take their… Continue reading

Preliminary Psychometrics of the Neurological Disorders Depression Inventory for Epilepsy-Youth.

Preliminary Psychometrics of the Neurological Disorders Depression Inventory for Epilepsy-Youth.

J Child Neurol. 2013 Apr 10;
Wagner JL, Smith G, Ferguson PL, Fedele DA

The authors examined the preliminary psychometrics of a depression screening tool for youth with epilepsy.… Continue reading

Physical Activity and Depression Symptom Profiles in Young Men and Women With Major Depression.

Physical Activity and Depression Symptom Profiles in Young Men and Women With Major Depression.

Psychosom Med. 2013 Apr 10;
McKercher C, Patton GC, Schmidt MD, Venn AJ, Dwyer T, Sanderson K

ObjectiveThis study explored whether young adults with major… Continue reading

Safety and Acceptability of Practice-Nurse-Managed Care of Depression in Patients With Diabetes or Heart Disease in the Australian TrueBlue Study.

Safety and acceptability of practice-nurse-managed care of depression in patients with diabetes or heart disease in the Australian TrueBlue study.

BMJ Open. 2013; 3(4):
Schlicht K, Morgan MA, Fuller J, Coates MJ, Dunbar JA

To determine the safety and… Continue reading